Skip to main content

Dr. Daniel C. Rodrigue, MD

Infectious Disease (Infectious Disease Physician)

  • Medicare participating

At a glance

Years since graduation
42
In the NPI registry since
2005
Medicare patients seen, 2024
266

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1984Medical school: University of California, Davis School of Medicine
  • 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Infectious Disease Physician primary
    KY license 35252

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Infectious Disease per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
266
Services billed
76,764
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, daptomycin, 1 mg80,65031
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes768152
Injection, ceftriaxone sodium, per 250 mg73234
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less25975
Established patient office or other outpatient visit, 30-39 minutes24089
Injection, ertapenem sodium, 500 mg24031
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes21086
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes161140
Critical care, first 30-74 minutes15042
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less12226

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Daptomycin87
Ceftriaxone (ceftriaxone sodium)
Other prescribers in Lexington, KY
66
Doxycycline Hyclate
Other prescribers in Lexington, KY
60
Sodium Chloride (0.9 % sodium chloride)
Other prescribers in Lexington, KY
44
Triumeq (abacavir/dolutegravir/lamivudi)43
Vancomycin Hcl38
Doxycycline Monohydrate
Other prescribers in Lexington, KY
32
Ertapenem (ertapenem sodium)31
Piperacillin-Tazobactam (piperacillin sodium/tazobactam)25
Meropenem24

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 31 payments worth $13,368 in total to this clinician.

By company
Merck Sharp & Dohme LLC$12,873
Insmed, Inc.$210
Gilead Sciences, Inc.$175
Astellas Pharma US Inc$53.29
Viiv Healthcare Company$32.20
Theratechnologies Inc.$24.38
By type
Compensation for services other than consulting (speaking, faculty)$9,500
Travel and Lodging$3,031
Food and Beverage$826
Education$10.85

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 12, 2025Merck Sharp & Dohme LLC
Sep 12, 2025
Compensation for services other than consulting (speaking, faculty)
ZERBAXA · INFECTIOUS DISEASE
$4,320
May 16, 2025Merck Sharp & Dohme LLC
May 16, 2025
Compensation for services other than consulting (speaking, faculty)
ZERBAXA · INFECTIOUS DISEASE
$2,590
Apr 25, 2025Merck Sharp & Dohme LLC
Apr 25, 2025
Compensation for services other than consulting (speaking, faculty)
ZERBAXA · INFECTIOUS DISEASE
$2,590
Aug 19, 2025Merck Sharp & Dohme LLC
Aug 19, 2025
Travel and Lodging
ZERBAXA · INFECTIOUS DISEASE · travel to Indianapolis, IN · in-kind
$1,621
Apr 17, 2025Merck Sharp & Dohme LLC
Apr 17, 2025
Travel and Lodging
ZERBAXA · INFECTIOUS DISEASE · travel to Louisville, KY · in-kind
$1,160
Sep 12, 2025Merck Sharp & Dohme LLC
Sep 12, 2025
Travel and Lodging
ZERBAXA · INFECTIOUS DISEASE · travel to Indianapolis, IN
$150
Apr 25, 2025Merck Sharp & Dohme LLC
Apr 25, 2025
Travel and Lodging
ZERBAXA · INFECTIOUS DISEASE · travel to Louisville, KY
$75.00
May 16, 2025Merck Sharp & Dohme LLC
May 16, 2025
Travel and Lodging
ZERBAXA · INFECTIOUS DISEASE · travel to Lexington, KY
$25.00
Apr 10, 2025Merck Sharp & Dohme LLC
Apr 10, 2025
Education
ZERBAXA · INFECTIOUS DISEASE · in-kind
$10.85

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Kentucky →

Other Infectious Disease clinicians in Lexington

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 4, 2008), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1386645661. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.